Phase I/II study of galiximab, an anti-CD80 antibody, for relapsed or refractory follicular lymphoma (Q81919524)
Jump to navigation
Jump to search
scientific article published on 01 July 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I/II study of galiximab, an anti-CD80 antibody, for relapsed or refractory follicular lymphoma |
scientific article published on 01 July 2005 |
Statements
Phase I/II study of galiximab, an anti-CD80 antibody, for relapsed or refractory follicular lymphoma (English)
Myron S Czuczman
Aron Thall
Thomas E Witzig
Anas Younes
Christos Emmanouilides
Thomas P Miller
Joseph O Moore
John P Leonard
John Sweetenham
Baha Alkuzweny
Deborah M Finucane
Bryan R Leigh